Expression of Vascular Endothelial Growth Factor, Receptor KDR and p53 Protein in Transitional Cell Carcinoma of the Bladder

Publisher： Karger

E-ISSN： 1423-0399|81|1|72-76

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.81, Iss.1, 2008-07, pp. : 72-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neoangiogenesis and Relationship to Nuclear p53 Accumulation and Vascular Endothelial Growth Factor Expression in Advanced Gastric Carcinoma

By  

Oncology, Vol. 57, Iss. 2, 1999-08 ,pp. : 164-172

Karger

Access to resources Recommend Favorite

The Correlation of p53 Protein Overexpression and p53 Antibodies in Serum of Patients with Transitional Cell Carcinoma of the Urinary Bladder

By  

Urologia Internationalis, Vol. 64, Iss. 1, 2000-04 ,pp. : 13-17

Karger

Access to resources Recommend Favorite

Adenoviral Receptor Expression of Normal Bladder and Transitional Cell Carcinoma of the Bladder

By  

Urologia Internationalis, Vol. 78, Iss. 2, 2007-02 ,pp. : 160-166

Karger

Access to resources Recommend Favorite

Expression of p53 and Vascular Endothelial Growth Factor Associated with Tumor Angiogenesis and Prognosis in Gastric Cancer

By  

Oncology, Vol. 55, Iss. 6, 1998-10 ,pp. : 594-599

Karger

Access to resources Recommend Favorite

In vitro study of normoxic epidermal growth factor receptor–induced hypoxia‐inducible factor‐1‐alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti–epidermal growth factor receptor therapy

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 8, 2015-08 ,pp. : 1150-1162

John Wiley & Sons Inc

Access to resources Recommend Favorite